GIP RECEPTOR AGONIST AND USE THEREOF
The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LI, Wenchen LI, Honghao XIE, Haisong ZHAO, Yingchi XU, Hongmei |
| description | The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity at GIP receptors and selectively activate the GIP receptors, and may be used in the manufacture of medicaments associated with type 2 diabetes and weight loss. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024239863A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024239863A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024239863A13</originalsourceid><addsrcrecordid>eNrjZFBx9wxQCHJ1dg0I8Q9ScHT39_MMDlFw9HNRCA12VQjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmRsaWFmbGjobGxKkCAPiVI9M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GIP RECEPTOR AGONIST AND USE THEREOF</title><source>esp@cenet</source><creator>LI, Wenchen ; LI, Honghao ; XIE, Haisong ; ZHAO, Yingchi ; XU, Hongmei</creator><creatorcontrib>LI, Wenchen ; LI, Honghao ; XIE, Haisong ; ZHAO, Yingchi ; XU, Hongmei</creatorcontrib><description>The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity at GIP receptors and selectively activate the GIP receptors, and may be used in the manufacture of medicaments associated with type 2 diabetes and weight loss.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=US&NR=2024239863A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25546,76297</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240718&DB=EPODOC&CC=US&NR=2024239863A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI, Wenchen</creatorcontrib><creatorcontrib>LI, Honghao</creatorcontrib><creatorcontrib>XIE, Haisong</creatorcontrib><creatorcontrib>ZHAO, Yingchi</creatorcontrib><creatorcontrib>XU, Hongmei</creatorcontrib><title>GIP RECEPTOR AGONIST AND USE THEREOF</title><description>The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity at GIP receptors and selectively activate the GIP receptors, and may be used in the manufacture of medicaments associated with type 2 diabetes and weight loss.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBx9wxQCHJ1dg0I8Q9ScHT39_MMDlFw9HNRCA12VQjxcA1y9XfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmRsaWFmbGjobGxKkCAPiVI9M</recordid><startdate>20240718</startdate><enddate>20240718</enddate><creator>LI, Wenchen</creator><creator>LI, Honghao</creator><creator>XIE, Haisong</creator><creator>ZHAO, Yingchi</creator><creator>XU, Hongmei</creator><scope>EVB</scope></search><sort><creationdate>20240718</creationdate><title>GIP RECEPTOR AGONIST AND USE THEREOF</title><author>LI, Wenchen ; LI, Honghao ; XIE, Haisong ; ZHAO, Yingchi ; XU, Hongmei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024239863A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI, Wenchen</creatorcontrib><creatorcontrib>LI, Honghao</creatorcontrib><creatorcontrib>XIE, Haisong</creatorcontrib><creatorcontrib>ZHAO, Yingchi</creatorcontrib><creatorcontrib>XU, Hongmei</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI, Wenchen</au><au>LI, Honghao</au><au>XIE, Haisong</au><au>ZHAO, Yingchi</au><au>XU, Hongmei</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GIP RECEPTOR AGONIST AND USE THEREOF</title><date>2024-07-18</date><risdate>2024</risdate><abstract>The present invention is in the field of biomedical technology, and discloses a peptide compound having agonistic activity at glucose-dependent insulinotropic polypeptide (GIP) receptors, and use the peptide compound. The compound provided by the present invention has an improved agonistic activity at GIP receptors and selectively activate the GIP receptors, and may be used in the manufacture of medicaments associated with type 2 diabetes and weight loss.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2024239863A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | GIP RECEPTOR AGONIST AND USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A38%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI,%20Wenchen&rft.date=2024-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024239863A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |